These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 5061521

  • 21. [Uncouplers (author's transl)].
    Terada H, Muraoka S.
    Tanpakushitsu Kakusan Koso; 1973 Oct; 18(10):911-9. PubMed ID: 4271985
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Role of bioenergetic changes in the mechanism of action of nonsteroid anti-inflammatory agents].
    Leschinskiĭ AF.
    Biull Eksp Biol Med; 1976 Oct; 81(4):436-8. PubMed ID: 179649
    [Abstract] [Full Text] [Related]

  • 27. Quantitative analysis of uncoupling activity of substituted phenols with a physicochemical substituent and molecular parameters.
    Miyoshi H, Tsujishita H, Tokutake N, Fujita T.
    Biochim Biophys Acta; 1990 Mar 15; 1016(1):99-106. PubMed ID: 2310745
    [Abstract] [Full Text] [Related]

  • 28. Structural requirements of salicylanilides for uncoupling activity in mitochondria: quantitative analysis of structure-uncoupling relationships.
    Terada H, Goto S, Yamamoto K, Takeuchi I, Hamada Y, Miyake K.
    Biochim Biophys Acta; 1988 Dec 07; 936(3):504-12. PubMed ID: 3196713
    [Abstract] [Full Text] [Related]

  • 29. Structure-activity relationships of fenamic acids.
    Terada H, Muraoka S, Fujita T.
    J Med Chem; 1974 Mar 07; 17(3):330-4. PubMed ID: 4811229
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
    Latham BA, Radcliff F, Robinson RG.
    Ann Phys Med; 1966 Aug 07; 8(7):242-3. PubMed ID: 5918265
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
    Linari G, Spanò R.
    Farmaco Sci; 1971 Apr 07; 26(4):303-11. PubMed ID: 5559990
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Uncoupling of oxidative phosphorylation by tribromoimidazole derivatives and fatty acids.
    Parker VH.
    Biochem Pharmacol; 1973 May 15; 22(10):1203-19. PubMed ID: 4707603
    [No Abstract] [Full Text] [Related]

  • 37. Anti-complement effects of two anti-inflammatory agents. Niflumic and flufenamic acids.
    Harrity TW, Goldlust MB.
    Biochem Pharmacol; 1974 Nov 15; 23(22):3107-20. PubMed ID: 4216354
    [No Abstract] [Full Text] [Related]

  • 38. Synthesis of spin labelled 2,4-dinitrophenols and their activities in the uncoupling of oxidative phosphorylation in rat liver mitochondria.
    Hsia JC, Chen WL, Wong LT, Long RA, Kalow W.
    Biochem Biophys Res Commun; 1972 Sep 05; 48(5):1273-9. PubMed ID: 5054755
    [No Abstract] [Full Text] [Related]

  • 39. The fibrinolytic activity of anti-inflammatory drugs.
    Gryglewski R.
    J Pharm Pharmacol; 1966 Jul 05; 18(7):474. PubMed ID: 4381731
    [No Abstract] [Full Text] [Related]

  • 40. Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5'-triphosphate.
    Collier HO, James GW, Schneider C.
    Nature; 1966 Oct 22; 212(5060):411-2. PubMed ID: 4381910
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.